[Ca antagonists in neurosurgical practice].
Department of Neurosurgery, Shiga University of Medical Science, Ohtu, Japan.
J
J
Handa
A
A
Shiino
M
M
Kidooka
D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000188:drug therapy; D004195:Disease Models, Animal; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005444:Flunarizine / Q000627:therapeutic use; D006801:Humans; D002532:Intracranial Aneurysm / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009553:Nimodipine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D005230:Fatty Acids, Nonesterified; D010879:Piperazines; D009553:Nimodipine; D014700:Verapamil; C052424:lomerizine; D005444:Flunarizine